Description

(3aS)-2-[[4-O-(Aminocarbonyl)-2-[[[(iminomethyl)amino]acetyl](methyl)amino]-2-deoxy-β-D-glucopyranosyl]amino]-1,3aβ,5,6,7,7aα-hexahydro-7β-hydroxy-5-methyl-4H-imidazo[4,5-c]pyridin-4-one is a complex, high-purity nucleoside analog derivative of significant interest in advanced pharmaceutical research and development. Its intricate molecular structure, featuring a modified sugar moiety and an imidazopyridinone base, makes it a critical intermediate for synthesizing novel therapeutic agents. This compound is primarily sought by research institutions and pharmaceutical companies engaged in the discovery of antiviral and anticancer drugs, where precise molecular architecture is paramount for biological activity.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel nucleoside-based antiviral medications.
• Anticancer Drug Research: Used in R&D for developing targeted therapies that interfere with DNA/RNA synthesis in cancer cells.
• Biochemical Research: Acts as a substrate or inhibitor in enzymatic studies related to nucleotide metabolism and processing.
• Proteomics & Molecular Biology: Utilized in the development of specialized probes and tools for studying genetic expression and cellular processes.
• Pre-clinical Development: Employed in the synthesis of candidate compounds for pharmacokinetic and toxicology studies.
• Reference Standard: Provides a high-purity standard for analytical method development and quality control in API manufacturing.

Basic Information

Item	Details
Product Name	(3aS)-2-[[4-O-(Aminocarbonyl)-2-[[[(iminomethyl)amino]acetyl](methyl)amino]-2-deoxy-β-D-glucopyranosyl]amino]-1,3aβ,5,6,7,7aα-hexahydro-7β-hydroxy-5-methyl-4H-imidazo[4,5-c]pyridin-4-one
CAS No.	29266-98-6
Molecular Formula	C₁₉H₂₉N₉O₈
Molecular Weight	511.49 g/mol
Synonyms	1,3aβ,5,6,7,7aα-Hexahydro-7β-hydroxy-5-methyl-2-[[4-O-(aminocarbonyl)-2-[[[(iminomethyl)amino]acetyl](methyl)amino]-2-deoxy-β-D-glucopyranosyl]amino]-4H-imidazo[4,5-c]pyridin-4-one; 2'-Deoxy-2'-(N-methyl-N-glycylamidino)cytidine derivative; Nucleoside analog intermediate; Modified cytidine derivative; Imidazo[4,5-c]pyridinone nucleoside; Glycylamidino nucleoside; CAS 29266-98-6
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency for critical research applications. Quality is verified through comprehensive analytical techniques including HPLC, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting purity, identity, and impurity profiles. We support compliance with cGMP guidelines for pharmaceutical starting materials upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.